United Capital Financial Advisers, LLC Sanofi Transaction History

United Capital Financial Advisers, LLC

$19.9 Billion
Q3 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Sanofi stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 71,374 shares of SNY stock, worth $3.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

71,374

Previous 74,247 3.87%

Holding current value

$3.88 Million

Previous $3.6 Million 14.24%

% of portfolio

0.02%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$48.54 - $58.53 $139,455 - $168,156	-2,873 Reduced 3.87%	71,374 $4.12 Million
Q2 2024 Aug 14, 2024	SELL	$45.39 - $50.36 $250,280 - $277,685	-5,514 Reduced 6.91%	74,247 $3.6 Million
Q1 2024 May 15, 2024	SELL	$45.75 - $52.48 $1.11 Million - $1.28 Million	-24,368 Reduced 23.4%	79,761 $3.88 Million
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $7.14 Million - $9.08 Million	-165,656 Reduced 61.4%	104,129 $5.18 Million
Q3 2023 Nov 14, 2023	SELL	$50.95 - $55.2 $121,159 - $131,265	-2,378 Reduced 0.87%	269,785 $14.5 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $38,190 - $43,285	757 Added 0.28%	272,163 $14.7 Million
Q1 2023 Aug 14, 2023	SELL	$45.86 - $54.45 $57,783 - $68,607	-1,260 Reduced 0.46%	270,903 $14.7 Million
Q1 2023 May 15, 2023	BUY	$45.86 - $54.45 $10.7 Million - $12.7 Million	233,152 Added 609.48%	271,406 $14.8 Million
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $57,046 - $71,271	-1,468 Reduced 3.7%	38,254 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $44,031 - $118,891	1,183 Added 3.07%	39,722 $1.51 Million
Q2 2022 Aug 11, 2022	BUY	$48.99 - $57.46 $56,142 - $65,849	1,146 Added 3.06%	38,539 $1.93 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $57,254 - $63,360	1,181 Added 3.26%	37,393 $1.92 Million
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $114,144 - $126,948	-2,425 Reduced 6.28%	36,212 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $39,078 - $43,345	816 Added 2.16%	38,637 $1.86 Million
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $45,954 - $50,506	-931 Reduced 2.4%	37,821 $1.99 Million
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $46,005 - $51,116	1,012 Added 2.68%	38,752 $1.92 Million
Q4 2020 Feb 17, 2021	BUY	$45.3 - $51.62 $33,657 - $38,353	743 Added 2.01%	37,740 $1.83 Million
Q3 2020 Nov 13, 2020	BUY	$49.47 - $53.77 $71,533 - $77,751	1,446 Added 4.07%	36,997 $1.86 Million
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $15,061 - $18,427	351 Added 1.0%	35,551 $1.82 Million
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $296,670 - $403,102	-7,803 Reduced 18.15%	35,200 $1.54 Million
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $356,743 - $410,033	8,062 Added 23.07%	43,003 $2.16 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $549,309 - $635,096	-13,617 Reduced 28.04%	34,941 $1.62 Million
Q2 2019 Aug 13, 2019	BUY	$40.43 - $44.3 $258,994 - $283,785	6,406 Added 15.2%	48,558 $2.1 Million
Q1 2019 May 14, 2019	SELL	$40.83 - $45.43 $249,512 - $277,622	-6,111 Reduced 12.66%	42,152 $1.87 Million
Q4 2018 Feb 14, 2019	BUY	$41.48 - $45.59 $160,112 - $175,977	3,860 Added 8.69%	48,263 $2.1 Million
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $92,520 - $103,714	2,313 Added 5.5%	44,403 $1.98 Million
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $62,578 - $68,548	1,663 Added 4.11%	42,090 $1.68 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $45.76 $1.58 Million - $1.85 Million	40,427 New	40,427 $1.62 Million
Q4 2017 Feb 13, 2018	SELL	$42.86 - $50.61 $1.52 Million - $1.8 Million	-35,528 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$47.04 - $50.34 $39,137 - $41,882	-832 Reduced 2.29%	35,528 $1.77 Million
Q2 2017 Aug 14, 2017	BUY	N/A	36,360	36,360 $1.74 Million

Others Institutions Holding SNY

# of Institutions

810

Shares Held

267M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Sanofi Transaction History